Is it really time to perform large intervention trials with antioxidant vitamins to prevent cardiovascular disease?

Pharmacological Research

Volumn 40, Issue 3, 1999, Pages 207-208

  Bellomo, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; VITAMIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG DELIVERY SYSTEM; EDITORIAL; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN INTAKE;

EID: 0032880975     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0499     Document Type: Article

References (16)

1. R Marchioli Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical data Pharmacol Res 40 1999 227 238
2. MJ Stampfer CK Hennekens JE Manson Vitamin E consumption and the risk of coronary heart disease in women N Engl J Med 328 1993 1444 1449
3. EB Rimm MJ Stampfer A Ascherio E Giovannucci GA Colditz WC Willet Vitamin E consumption and the risk of coronary heart disease in men N Engl J Med 328 1993 1450 1456
4. NG Stephens A Parsons PM Schofield F Kelly K Cheeseman MJ Mitchinson Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study Lancet 347 1996 781 786
5. D Steinberg Low density lipoprotein oxidation and its pathobiological significance J Biol Chem 272 1997 20963 20966
6. W Palinski S Horkko Biological consequences of oxidation in atherosclerosis and other pathologies Nutr Metab Cardiovasc Dis 7 1997 237 247
7. A Daugherty BS Zweifel G Schonfeld Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits Br J Pharmacol 98 1989 612 618
8. DA Bird RK Tangirala J Fruebis D Steinberg JL Witztum W Palinski Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice J Lipid Res 39 1998 1079 1090
9. G Bellomo E Maggie G Palladini C Perugini M Seccia Endogenous and exogenous antioxidants and the generation of antigenic epitopes in oxidatively-modified LDL Biofactors 6 1997 91 98
10. VW Bowry KU Ingold R Stocker Vitamin E in human low density lipoprotein: when and how this antioxidant becomes a prooxidant Biochem J 288 1992 341 344
11. SE Stait DS Leake Ascorbic acid either increase or decrease low density lipoprotein modification FEBS Lett 341 1994 263 267
12. M Bagnati C Perugini C Cau R Bordone E Albano G Bellomo When and why a water-soluble antioxidant becomes prooxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid Biochem J 1999
13. LJ Hazell R Stocker Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 flow-density lipoprotein FEBS Lett 414 1997 541 544
14. M Seccia E Albano E Maggi G Bellomo Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein: evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation Arterioscler Thromb Vasc Biol 17 1997 134 140
15. A Azzi E Aratri D Boscoboinik S Clement NK Ozer R Ricciarelli S Spycher Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation Biofactors 7 1998 3 14
16. S Devaraj B Adams-Huet CJ Fuller I Jialal Dose–response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation Arterioscler Thromb Vasc Biol 17 1997 2273 2279